Search

Your search keyword '"Jamerson, Kenneth"' showing total 456 results
Start Over Author "Jamerson, Kenneth"
456 results on '"Jamerson, Kenneth"'

56. Strategies for implementing and sustaining therapeutic lifestyle changes as part of hypertension management in African Americans

Author

Scisney-Matlock, Margaret, Bosworth, Hayden B., Giger, Joyce Newman, Strickland, Ora L., Van Harrison, R., Coverson, Dorothy, Shah, Nirav R., Dennison, Cheryl R., Dunbar-Jacob, Jacqueline M., Jones, Loretta, Ogedegbe, Gbenga, Batts-Turner, Marian L., and Jamerson, Kenneth A.

Subjects
Hypertension -- Care and treatment, Hypertension -- Social aspects, African Americans -- Health aspects, Life style -- Health aspects, Health behavior -- Management, Weight loss maintenance -- Methods, Cultural competence -- Influence, Company business management, Health
Published
2009

57. Rationale and design of the avoiding cardiovascular events through combination therapy in patients living with systolic hypertension (ACCOMPLISH) trial: The first randomized controlled trial to compare the clinical outcome effects of first-line combination therapies in hypertension

Author

Jamerson, Kenneth A., Bakris, George L., Wun, Chuan-Chuan, Dahlöf, Björn, Lefkowitz, Martin, Manfreda, Sheryl, Pitt, Bertram, Velazquez, Eric J., and Weber, Michael A.

Published
2004
Full Text
View/download PDF

59. Management of High Blood Pressure in African Americans: Consensus Statement of the Hypertension in African Americans Working Group of the International Society on Hypertension in Blacks

Author

Douglas, Janice G., Bakris, George L., Epstein, Murray, Ferdinand, Keith C., Ferrario, Carlos, Flack, John M., Jamerson, Kenneth A., Jones, Wendell E., Haywood, Julian, Maxey, Randall, Ofili, Elizabeth O., Saunders, Elijah, Schiffrin, Ernesto L., Sica, Domenic A., Sowers, James R., and Vidt, Donald G.

Published
2003

60. Effect of Ramipril vs Amlodipine on Renal Outcomes in Hypertensive Nephrosclerosis: A Randomized Controlled Trial

Author

Agodoa, Lawrence Y., Appel, Lawrence, Bakris, George L., Beck, Gerald, Bourgoignie, Jacques, Briggs, Josephine P., Charleston, Jeanne, Cheek, DeAnna, Cleveland, William, Douglas, Janice G., Douglas, Margaret, Dowie, Donna, Faulkner, Marquetta, Gabriel, Avril, Gassman, Jennifer, Greene, Tom, Hall, Yvette, Hebert, Lee, Hiremath, Leena, Jamerson, Kenneth, Johnson, Carolyn J., Kopple, Joel, Kusek, John, Lash, James, Lea, Janice, Lewis, Julia B., Lipkowitz, Michael, Massry, Shaul, Middleton, John, Miller, Edgar R., III, Norris, Keith, O'Connor, Daniel, Ojo, Akinlou, Phillips, Robert A., Pogue, Velvie, Rahman, Mahboob, Randall, Otelio S., Rostand, Stephen, Schulman, Gerald, Smith, Winifred, Thornley-Brown, Denyse, Tisher, C. Craig, Toto, Robert D., Wright, Jackson T., Jr, and Xu, Shichen

Published
2001

62. Cardiovascular Benefits of Angiotensin-Converting Enzyme Inhibition Plus Calcium Channel Blockade in Patients Achieving Tight Blood Pressure Control and With Resistant Hypertension.

Author

Brook, Robert D, Kaciroti, Niko, Bakris, George, Dahlöf, Björn, Pitt, Bertrtam, Velazquez, Eric, Weber, Michael A, and Jamerson, Kenneth A

Subjects
ANTIHYPERTENSIVE agents, ACE inhibitors, BLOOD pressure, ANGIOTENSIN converting enzyme, CALCIUM channels, SYSTOLIC blood pressure, HYPERTENSION
Abstract

BACKGROUND The 2017 hypertension guidelines lowered systolic blood pressure (BP) goals to <130 mm Hg and redefined resistant hypertension. We investigated if these changes alter the cardiovascular benefits demonstrated by combining a calcium channel blocker (CCB), rather than hydrochlorothiazide (HCTZ), with an angiotensin-converting enzyme inhibitor (ACEI). METHODS In this post hoc analysis of the Avoiding Cardiovascular Events Through Combination Therapy in Patients Living with Systolic Hypertension trial (n = 11,506), we compared the primary composite outcome (cardiovascular death, myocardial infarction, stroke, hospitalization for angina, resuscitation after sudden cardiac death, and coronary revascularization) between the 2 combination-treatment limbs in patients achieving a systolic BP ≤130 mm Hg and those with "apparent resistant hypertension" (prescribed ≥4 antihypertensive medications). RESULTS Among study patients, 5,221 (45.4%) achieved a systolic BP ≤130 mm Hg. There were fewer primary endpoints in the amlodipine/benazepril (9.2%) vs. the HCTZ/benazepril (10.9%) limb (adjusted hazard ratio [HR] 0.83, 95% confidence interval [CI], 0.70–0.99). There were also fewer primary endpoints in the amlodipine/benazepril (12.8%) vs. the HCTZ/benazepril (15.2%) limb (n = 4,451, 38.7%) among patients with apparent resistant hypertension (HR 0.81, 95% CI, 0.70–0.95). CONCLUSIONS Combination therapy adding a CCB, rather than HCTZ, to an ACEI was more effective in preventing composite cardiovascular events even in hypertensive patients achieving aggressive systolic BP targets as well as in those with apparent resistant hypertension. Our findings add support that most patients, including those following contemporary clinical guidelines, will benefit from this combination. CLINICAL TRIALS REGISTRATION Trial Number NCT00170950. [ABSTRACT FROM AUTHOR]

Published
2021
Full Text
View/download PDF

63. The association of borderline hypertension with target organ changes and higher coronary risk: Tecumseh blood pressure study

Author

Julius, Stevo, Jamerson, Kenneth, Mejia, Agnes, Krause, Lisa, Schork, Nicholas, and Jones, Kerin

Subjects
Atherosclerosis -- Risk factors, Mild hypertension -- Complications, Cardiovascular diseases -- Risk factors, Hypertension in children -- Prognosis
Abstract

The association of borderline hypertension (blood pressure elevated above normal, but not dramatically so) with risk factors for cardiovascular disease is being studied in an ongoing project in Tecumseh, Michigan. Results from 946 healthy subjects (124 borderline, 822 normotensive) aged 18 to 38 years are presented. Blood pressure (BP), cardiac output (the volume of blood pumped by the heart), minimal forearm resistance (a measure of the resistance offered to blood flow by thicker blood vessels), levels of various substances in the blood, and body weight were evaluated for all subjects. Borderline hypertension was defined as exceeding 140 mm Hg systolic (during the heart's contracting phase) and/or 90 mm Hg diastolic (during the resting phase), when BP was measured in the clinic. Results showed that the borderline hypertension group had higher heart rates, lower stroke volume (amount of blood pumped with each heartbeat), and elevated vascular resistance and minimal forearm vascular resistance (indicating less compliant vessels). Other heart disease risk factors, such as blood cholesterol levels, were greater for this group. These subjects were an average of 29 pounds heavier than subjects in the normotensive group. Skinfold thickness (a measure of fat deposition under the skin) was higher in the borderline hypertensive group. This and other correlations between BP and cardiovascular risk factors were due to hypertensive subjects tending to be overweight. Longitudinal analysis showed that adults with borderline hypertension had had higher BP in the first decade of life than normotensive subjects. The difference intensified at the age of 21. Even if they had thicker skinfolds, subjects who had had normal BP at age six did not tend to develop hypertension. On the other hand, half of the children with higher BP, but normal skinfolds, became borderline hypertensive as adults. Borderline hypertensives had a family history of higher BP. The results show that borderline hypertension begins in childhood, and that it is associated with several risk factors for heart disease. Identification of people with this potentially dangerous condition should lead to earlier intervention. (Consumer Summary produced by Reliance Medical Information, Inc.)

Published
1990

64. Early Rapid Decline in Kidney Function in Medically Managed Patients With Atherosclerotic Renal Artery Stenosis

Author

Cooper, Emily L., primary, Xie, Yanmei, additional, Nguyen, Hanh, additional, Brewster, Pamela S., additional, Sholl, Haden, additional, Sharrett, Megan, additional, Ren, Kaili, additional, Chen, Tian, additional, Tuttle, Katherine R., additional, Haller, Steven T., additional, Jamerson, Kenneth, additional, Murphy, Timothy P., additional, D'Agostino, Ralph B., additional, Massaro, Joseph M., additional, Henrich, William, additional, Cooper, Christopher J., additional, Cutlip, Donald E., additional, Dworkin, Lance D., additional, and Shapiro, Joseph I., additional

Published
2019
Full Text
View/download PDF

65. Prediction of cardiovascular outcomes with machine learning techniques: application to the Cardiovascular Outcomes in Renal Atherosclerotic Lesions (CORAL) study

Author

Chen, Tian, primary, Brewster, Pamela, additional, Tuttle, Katherine, additional, Dworkin, Lance, additional, Henrich, William, additional, Greco, Barbara, additional, Steffes, Michael, additional, Tobe, Sheldon, additional, Jamerson, Kenneth, additional, Pencina, Karol, additional, Massaro, Joseph, additional, D'Agostino Sr, Ralph, additional, Cutlip, Donald, additional, Murphy, Timothy, additional, Cooper, Christopher, additional, and Shapiro, Joseph, additional

Published
2019
Full Text
View/download PDF

67. Cardiovascular Events after New-Onset Atrial Fibrillation in Adults with CKD: Results from the Chronic Renal Insufficiency Cohort (CRIC) Study

Author

Bansal, Nisha, primary, Xie, Dawei, additional, Sha, Daohang, additional, Appel, Lawrence J., additional, Deo, Rajat, additional, Feldman, Harold I., additional, He, Jiang, additional, Jamerson, Kenneth, additional, Kusek, John W., additional, Messe, Steven, additional, Navaneethan, Sankar D., additional, Rahman, Mahboob, additional, Ricardo, Ana Catherine, additional, Soliman, Elsayed Z., additional, Townsend, Raymond, additional, and Go, Alan S., additional

Published
2018
Full Text
View/download PDF

68. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines

Author

Whelton, Paul K., primary, Carey, Robert M., additional, Aronow, Wilbert S., additional, Casey, Donald E., additional, Collins, Karen J., additional, Dennison Himmelfarb, Cheryl, additional, DePalma, Sondra M., additional, Gidding, Samuel, additional, Jamerson, Kenneth A., additional, Jones, Daniel W., additional, MacLaughlin, Eric J., additional, Muntner, Paul, additional, Ovbiagele, Bruce, additional, Smith, Sidney C., additional, Spencer, Crystal C., additional, Stafford, Randall S., additional, Taler, Sandra J., additional, Thomas, Randal J., additional, Williams, Kim A., additional, Williamson, Jeff D., additional, and Wright, Jackson T., additional

Published
2018
Full Text
View/download PDF

69. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines

Author

Whelton, Paul K., primary, Carey, Robert M., additional, Aronow, Wilbert S., additional, Casey, Donald E., additional, Collins, Karen J., additional, Dennison Himmelfarb, Cheryl, additional, DePalma, Sondra M., additional, Gidding, Samuel, additional, Jamerson, Kenneth A., additional, Jones, Daniel W., additional, MacLaughlin, Eric J., additional, Muntner, Paul, additional, Ovbiagele, Bruce, additional, Smith, Sidney C., additional, Spencer, Crystal C., additional, Stafford, Randall S., additional, Taler, Sandra J., additional, Thomas, Randal J., additional, Williams, Kim A., additional, Williamson, Jeff D., additional, and Wright, Jackson T., additional

Published
2018
Full Text
View/download PDF

70. Smoking and overweight associated with masked uncontrolled hypertension: a Hypertension Optimal Treatment (HOT) Sub-Study.

Author

Holanger, Magnus, Kjeldsen, Sverre E., Jamerson, Kenneth, and Julius, Stevo

Subjects
HYPERTENSION, BLOOD pressure, BODY mass index, OBESITY
Abstract

The Hypertension Optimal Treatment (HOT) Study investigated the relationship between target office diastolic blood pressure (BP) ≤80, ≤85 or ≤90 mmHg and cardiovascular morbidity and mortality in 18,790 patients aged 50–80 years. The home BP sub-study enrolled 926 patients and the aim was to clarify whether the separation into the BP target groups in the office prevailed in the out-of-office setting. The present study aimed to identify variables that characterised masked uncontrolled hypertension (MUCH) and white coat uncontrolled hypertension (WUCH). The sub-study participants took their home BP when office BP had been up titrated. The cut-off for normal or high BP was set to ≥135/85 mmHg at home and ≥140/90 mmHg in the office. We analysed data by using multivariate and stepwise multivariate logistic regression with home and office BP combinations as the dependent variables. WUCH was associated with lower body mass index (BMI) (odds ratio (OR) 0.92, 95% confident intervals (CIs) 0.88–0.96, p < 0.001). MUCH was associated with smoking (OR 1.89, 95% CIs 1.25–2.86, p = 0.0025) and with lower baseline heart rate (OR 0.98, 95% CIs 0.97–0.99, p = 0.03) and higher BMI (OR 1.03, CIs 1.00–1.06, p = 0.04). MUCH remained associated with smoking (OR 2.76, 95% CIs 1.76–4.35, p < 0.0001) also when using ≥140/90 mmHg as the cut-off for both home and office BP. MUCH was also associated with higher BMI (OR 1.05, 95% CIs 1.01–1.09, p = 0.009) while WUCH was associated with lower BMI (OR 0.93, 95% CIs 0.90–0.97, p = 0.0005) when using ≥140/90 mmHg as a cut-off. Our data support that 'reversed or masked' treated but uncontrolled hypertension (MUCH) is common and constitutes about 25% of treated hypertensive patients. This entity (MUCH) is rather strongly associated with current smoking and overweight while uncontrolled white coat (office) hypertension (WUCH) is associated with lower BMI. [ABSTRACT FROM AUTHOR]

Published
2021
Full Text
View/download PDF

71. The impact of ethnicity on response to antihypertensive therapy

Author

Jamerson, Kenneth and DeQuattro, Vincent

Subjects
Hypertension -- Drug therapy, Antihypertensive drugs -- Adverse and side effects, Health and race -- Physiological aspects, Health, Health care industry
Abstract

The aim of this review is to assess the prevalence of complications and responses to various antihypertensive drug therapies in ethnic minority groups in the United States. In some instances, these comments are extended to responses of citizens in their countries of origin. The incidence of hypertension, mortality from hypertensive heart disease, stroke, and hypertensive renal disease are higher in African Americans. Although some Hispanic Americans have a lesser risk for hypertension, they have a greater risk for other risk factors such as diabetes and dyslipidemia. There is a similar association between income and mortality for both African Americans and Hispanic Americans. When compared to European Americans and other ethnic minorities, African Americans respond less favorably to [Beta] blockers and angiotensin-converting enzyme (ACE) inhibitors. Nevertheless, the observed response in African Americans to ACE inhibitors and [Beta] blockers is clinically significant. The available literature indicates that Asian American responses to calcium antagonists seem to be more favorable than responses to ACE inhibitors and equivalent to their responses to diuretic and [Beta] blocker therapy. Although there are few published studies of drug efficacy in Hispanic Americans, there appears to be no hierarchy in response to the various antihypertensive drug classes. Ethnicity is not an accurate criterion for predicting poor response to any class of antihypertensive therapy. Thus, there is little justification to use racial profiling as a criterion for the avoidance of selected drug classes because of presumed lack of efficacy. Observed differences in the incidence of hypertension and its poor outcomes have led some investigators to postulate that the etiology of hypertension in ethnic minority groups is intrinsically different from whites. Awareness of racial differences in hypertension outcomes evolved in the United States within a historical context that does not fully appreciate that race is often a surrogate for many social and economic factors that influence health status and healthcare delivery. Poor outcomes in ethnic minority groups occur in many diseases, not only hypertension. The goal of ethnicity-related research should be to describe the diversity of disease expression in humans and to target at-risk groups for prevention and early intervention. The use of racial descriptors to explain genetic differences in ethnic groups should take a lesser priority.

Published
1996

72. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary

Author

Whelton, Paul K., primary, Carey, Robert M., additional, Aronow, Wilbert S., additional, Casey, Donald E., additional, Collins, Karen J., additional, Dennison Himmelfarb, Cheryl, additional, DePalma, Sondra M., additional, Gidding, Samuel, additional, Jamerson, Kenneth A., additional, Jones, Daniel W., additional, MacLaughlin, Eric J., additional, Muntner, Paul, additional, Ovbiagele, Bruce, additional, Smith, Sidney C., additional, Spencer, Crystal C., additional, Stafford, Randall S., additional, Taler, Sandra J., additional, Thomas, Randal J., additional, Williams, Kim A., additional, Williamson, Jeff D., additional, and Wright, Jackson T., additional

Published
2018
Full Text
View/download PDF

74. Lack of Longitudinal Association Between Thiazolidinediones and Incidence and Progression of Diabetic Eye Disease: The ACCORD Eye Study

Author

Gower, Emily W., primary, Lovato, James F., additional, Ambrosius, Walter T., additional, Chew, Emily Y., additional, Danis, Ronald P., additional, Davis, Matthew D., additional, Goff, David C., additional, Greven, Craig M., additional, Gotto, Antonio M., additional, Bailey, Kent, additional, Gohdes, Dorothy, additional, Haffner, Steven, additional, Hiss, Roland, additional, Jamerson, Kenneth, additional, Lee, Kerry, additional, Nathan, David, additional, Sowers, James, additional, and Walters, LeRoy, additional

Published
2018
Full Text
View/download PDF

75. Prior Medications and the Cardiovascular Benefits From Combination Angiotensin‐Converting Enzyme Inhibition Plus Calcium Channel Blockade Among High‐Risk Hypertensive Patients

Author

Brook, Robert D., primary, Kaciroti, Niko, additional, Bakris, George, additional, Dahlöf, Björn, additional, Pitt, Bertram, additional, Velazquez, Eric, additional, Weber, Michael, additional, Zappe, Dion H., additional, Hau, Tsushung, additional, and Jamerson, Kenneth A., additional

Published
2018
Full Text
View/download PDF

79. Cigarette smoking and cardio-renal events in patients with atherosclerotic renal artery stenosis

Author

Drummond, Christopher A., primary, Brewster, Pamela S., additional, He, Wencan, additional, Ren, Kaili, additional, Xie, Yanmei, additional, Tuttle, Katherine R., additional, Haller, Steven T., additional, Jamerson, Kenneth, additional, Dworkin, Lance D., additional, Cutlip, Donald E., additional, Murphy, Timothy P., additional, D’Agostino, Ralph B., additional, Henrich, William L., additional, Tian, Jiang, additional, Shapiro, Joseph I., additional, and Cooper, Christopher J., additional

Published
2017
Full Text
View/download PDF

81. Effects of Stenting for Atherosclerotic Renal Artery Stenosis on eGFR and Predictors of Clinical Events in the CORAL Trial

Author

Tuttle, Katherine R., primary, Dworkin, Lance D., additional, Henrich, William, additional, Greco, Barbara A., additional, Steffes, Michael, additional, Tobe, Sheldon, additional, Shapiro, Joseph I., additional, Jamerson, Kenneth, additional, Lyass, Asya, additional, Pencina, Karol, additional, Massaro, Joseph M., additional, D’Agostino, Ralph B., additional, Cutlip, Donald E., additional, Murphy, Timothy P., additional, and Cooper, Christopher J., additional

Published
2016
Full Text
View/download PDF

82. Cardiovascular Outcomes According to Systolic Blood Pressure in Patients With and Without Diabetes: An ACCOMPLISH Substudy

Author

Weber, Michael A., primary, Bloch, Michael, additional, Bakris, George L., additional, Weir, Matthew R., additional, Zappe, Dion H., additional, Dahlof, Bjorn, additional, Velazquez, Eric J., additional, Pitt, Bertram, additional, Basile, Jan N., additional, Jamerson, Kenneth, additional, and Hua, Tsushung A., additional

Published
2016
Full Text
View/download PDF

83. Renal Artery Stent Outcomes

Author

Murphy, Timothy P., primary, Cooper, Christopher J., additional, Matsumoto, Alan H., additional, Cutlip, Donald E., additional, Pencina, Karol M., additional, Jamerson, Kenneth, additional, Tuttle, Katherine R., additional, Shapiro, Joseph I., additional, D’Agostino, Ralph, additional, Massaro, Joseph, additional, Henrich, William, additional, and Dworkin, Lance D., additional

Published
2015
Full Text
View/download PDF

84. Abstract 17358: Stenting of Atherosclerotic Renal Artery Stenosis Does Not Prevent Congestive Heart Failure, an Analysis of the Coral Trial

Author

Ren, Kaili, primary, Xie, Yanmei, additional, Haller, Steven, additional, Yu, Mark, additional, He, Wencan, additional, Mei, Jingning, additional, Nguyen, Hanh, additional, Cooper, Emily, additional, Jamerson, Kenneth, additional, Murphy, Timothy P, additional, Cutlip, Donald E, additional, Dworkin, Lance, additional, Jaff, Michael R, additional, Steffes, Michael, additional, Shapiro, Joseph I, additional, Henrich, William, additional, Tian, Jiang, additional, Brewster, Pamela, additional, and Cooper, Christopher J, additional

Published
2015
Full Text
View/download PDF

85. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology/American Heart Association...

Author

Whelton, Paul K., Carey, Robert M., Aronow, Wilbert S., Casey, Donald E., Collins, Karen J., Dennison Himmelfarb, Cheryl, DePalma, Sondra M., Gidding, Samuel, Jamerson, Kenneth A., Jones, Daniel W., MacLaughlin, Eric J., Muntner, Paul, Ovbiagele, Bruce, Smith, Sidney C., Spencer, Crystal C., Stafford, Randall S., Taler, Sandra J., Thomas, Randal J., Williams, Kim A., and Williamson, Jeff D.

Abstract

Supplemental Digital Content is available in the text. [ABSTRACT FROM AUTHOR]

Published
2018
Full Text
View/download PDF

86. Meditation and Cardiovascular Risk Reduction: A Scientific Statement From the American Heart Association.

Author

Levine, Glenn N., Lange, Richard A., Bairey‐Merz, C. Noel, Davidson, Richard J., Jamerson, Kenneth, Mehta, Puja K., Michos, Erin D., Norris, Keith, Ray, Indranill Basu, Saban, Karen L., Shah, Tina, Stein, Richard, Smith, Sidney C., Bairey-Merz, C Noel, Smith, Sidney C Jr, and American Heart Association Council on Clinical Cardiology; Council on Cardiovascular and Stroke Nursing; and Council on Hypertension

Published
2017
Full Text
View/download PDF

87. Cigarette smoking and cardio-renal events in patients with atherosclerotic renal artery stenosis

Author

Drummond, Christopher A., primary, Brewster, Pamela S., additional, He, Wencan, additional, Ren, Kaili, additional, Evans, Kaleigh L., additional, Tuttle, Katherine R., additional, Yu, Shpeng, additional, Dawson, Taylor, additional, Haller, Steven T., additional, Jamerson, Kenneth, additional, Dworkin, Lance D., additional, Cutlip, Donald E., additional, Murphy, Timothy P., additional, D'Agostino, Ralph B., additional, Henrich, William, additional, Shaprio, Joseph I., additional, Cooper, Christopher J., additional, and Tian, Jiang, additional

Published
2015
Full Text
View/download PDF

88. Hypertension in African Americans Aged 60 to 79 Years: Statement From the International Society of Hypertension in Blacks

Author

Egan, Brent M., primary, Bland, Veita J., additional, Brown, Angela L., additional, Ferdinand, Keith C., additional, Hernandez, German T., additional, Jamerson, Kenneth A., additional, Johnson, Wallace R., additional, Kountz, David S., additional, Li, Jiexiang, additional, Osei, Kwame, additional, Reed, James W., additional, and Saunders, Elijah, additional

Published
2015
Full Text
View/download PDF

89. Use of Renin-Angiotensin Inhibitors in People with Renal Artery Stenosis

Author

Evans, Kaleigh L., primary, Tuttle, Katherine R., additional, Folt, David A., additional, Dawson, Taylor, additional, Haller, Steven T., additional, Brewster, Pamela S., additional, He, Wencan, additional, Jamerson, Kenneth, additional, Dworkin, Lance D., additional, Cutlip, Donald E., additional, Murphy, Timothy P., additional, D’Agostino, Ralph B., additional, Henrich, William, additional, and Cooper, Christopher J., additional

Published
2014
Full Text
View/download PDF

90. Prior antihypertensive regimen usage and the cardiovascular risk reduction derived from combination therapy with angiotensin converting enzyme inhibition-calcium channel blockade: a secondary analysis of the avoiding cardiovascular events through combinat

Author

Brook, Robert D., primary, Kaciroti, Niko, additional, Bakris, George, additional, Dahof, Bjorn, additional, Pitt, Bertram, additional, Velazquez, Eric, additional, Weber, Michael A., additional, and Jamerson, Kenneth A., additional

Published
2014
Full Text
View/download PDF

91. Exceptional early blood pressure control rates: The ACCOMPLISH trial

Author

Jamerson, Kenneth, primary, Bakris, George L., additional, Dahlöf, Björn, additional, Pitt, Bertram, additional, Velazquez, Eric, additional, Gupte, Jitendra, additional, Lefkowitz, Martin, additional, Hester, Allen, additional, Shi, Victor, additional, Kjeldsen, Sverre E., additional, Cushman, William, additional, Papademetriou, Vasilios, additional, Weber, Michael, additional, and Jamerson, Kenneth, additional

Published
2007
Full Text
View/download PDF

95. A Trial of 2 Strategies to Reduce Nocturnal Blood Pressure in Blacks With Chronic Kidney Disease

Author

Rahman, Mahboob, primary, Greene, Tom, additional, Phillips, Robert A., additional, Agodoa, Lawrence Y., additional, Bakris, George L., additional, Charleston, Jeanne, additional, Contreras, Gabriel, additional, Gabbai, Francis, additional, Hiremath, Leena, additional, Jamerson, Kenneth, additional, Kendrick, Cynthia, additional, Kusek, John W., additional, Lash, James P., additional, Lea, Janice, additional, Miller, Edgar R., additional, Rostand, Stephen, additional, Toto, Robert, additional, Wang, Xulei, additional, Wright, Jackson T., additional, and Appel, Lawrence J., additional

Published
2013
Full Text
View/download PDF

97. Relationship between Ambulatory BP and Clinical Outcomes in Patients with Hypertensive CKD

Author

Gabbai, Francis B., primary, Rahman, Mahboob, additional, Hu, Bo, additional, Appel, Lawrence J., additional, Charleston, Jeanne, additional, Contreras, Gabriel, additional, Faulkner, Marquetta L., additional, Hiremath, Leena, additional, Jamerson, Kenneth A., additional, Lea, Janice P., additional, Lipkowitz, Michael S., additional, Pogue, Velvie A., additional, Rostand, Stephen G., additional, Smogorzewski, Miroslaw J., additional, Wright, Jackson T., additional, Greene, Tom, additional, Gassman, Jennifer, additional, Wang, Xuelei, additional, and Phillips, Robert A., additional

Published
2012
Full Text
View/download PDF

98. Renal outcomes in hypertensive Black patients at high cardiovascular risk

Author

Weir, Matthew R., primary, Bakris, George L., additional, Weber, Michael A., additional, Dahlof, Bjorn, additional, Devereux, Richard B., additional, Kjeldsen, Sverre E., additional, Pitt, Bertram, additional, Wright, Jackson T., additional, Kelly, Roxzana Y., additional, Hua, Tsushung A., additional, Hester, R Allen, additional, Velazquez, Eric, additional, and Jamerson, Kenneth A., additional

Published
2012
Full Text
View/download PDF

99. Efficacy and Duration of Benazepril Plus Amlodipine or Hydrochlorthiazide on 24-Hour Ambulatory Systolic Blood Pressure Control

Author

Jamerson, Kenneth A., primary, Devereux, Richard, additional, Bakris, George L., additional, Dahlöf, Björn, additional, Pitt, Bertram, additional, Velazquez, Eric J., additional, Weir, Matthew, additional, Kelly, Roxzana Y., additional, Hua, Tsushung A., additional, Hester, Allen, additional, and Weber, Michael A., additional

Published
2011
Full Text
View/download PDF

100. Management of High Blood Pressure in Blacks

Author

Flack, John M., primary, Sica, Domenic A., additional, Bakris, George, additional, Brown, Angela L., additional, Ferdinand, Keith C., additional, Grimm, Richard H., additional, Hall, W. Dallas, additional, Jones, Wendell E., additional, Kountz, David S., additional, Lea, Janice P., additional, Nasser, Samar, additional, Nesbitt, Shawna D., additional, Saunders, Elijah, additional, Scisney-Matlock, Margaret, additional, and Jamerson, Kenneth A., additional

Published
2010
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results